Know What's Happening in Healthcare
Know What's Happening in Healthcare
FDA approves KRESLADI, first CIRM‑backed gene‑editing therapy
The FDA cleared KRESLADI, a gene‑editing treatment from Rocket Pharmaceuticals for severe leukocyte adhesion deficiency‑I in children, eliminating the need for a bone‑marrow donor. It is the first product directly funded by California’s Institute for Regenerative Medicine to receive approval.
Also developing:
By the numbers: Syneron Bio raises $150M Series B
IVF Academy USA unveiled a 30‑hour hybrid OBGYN Clinic‑Ready Fertility Services Accelerator, blending 14 hours of online coursework with a two‑day hands‑on residency. The program equips board‑certified OBGYNs to deliver in‑office fertility evaluations, IUI, and diagnostic hysteroscopy, complete with billing and coding guidance. Graduates can potentially generate about $189,000 in annual revenue per practitioner, with profit margins of 65‑70% and a break‑even window of three to four months. The inaugural cohort launches on May 1, 2026 with limited enrollment.
UnitedHealthcare introduced Avery, a generative AI companion designed to streamline care coordination for members. The tool currently assists about 6.5 million commercial and 160,000 Medicare Advantage members, with plans to reach 20.5 million across commercial, Medicare and Medicaid by year‑end. Avery can...
AdventHealth Ottawa, part of the Florida‑based AdventHealth system, reopened its Family Birth Place labor and delivery unit in September 2025 after a temporary closure in 2023. The hospital hired 11 full‑time maternity staff and plans additional providers in 2026, enabling...
Ocugen announced completion of patient enrollment for its Phase 3 liMeliGhT trial of OCU400, a modifier gene therapy for retinitis pigmentosa. The study enrolled 140 patients in a 2:1 treatment‑to‑control ratio and will assess visual function via the LDNA mobility test....
SELLAS Life Sciences announced it will present preclinical data on its CDK9 inhibitor SLS009 (tambiciclib) at the AACR 2026 meeting in San Diego. The poster highlights the drug’s ability to induce apoptosis and lower MCL‑1 levels in acute myeloid leukemia...
Medicare Part D is now available as an add‑on to many Federal Employees Health Benefits (FEHB) plans without an extra premium, offering comparable or better drug coverage and lower out‑of‑pocket costs. The plan caps annual drug spending at $2,100 (or $2,000...
MercyOne Clinton Medical Center will cease scheduled labor and delivery services after May 26, redirecting patients to MercyOne birth centers in Davenport, Dubuque and Silvis. The health system cited unsustainable demand, shifting demographics, staffing shortages and inadequate reimbursement as drivers...
The CDC confirmed 1,487 measles cases in the United States this year, edging toward the 1,600 mark. Utah now reports 486 infections, the largest single‑state tally, while South Carolina’s outbreak has surged past 990 cases. The rapid rise follows low...
Lawmakers introduced a bipartisan bill on March 26 to establish a permanent, full‑risk accountable care organization (ACO) program within traditional Medicare. The legislation seeks to transition successful CMS Innovation Center pilots into a lasting model that places financial risk on...
Acute Lymphocytic Leukemia (ALL) treatment follows a three‑phase protocol—induction, consolidation, and maintenance—to achieve remission and prevent relapse. Advanced options such as targeted therapies, CAR T‑cell immunotherapy, and stem cell transplantation are increasingly used, especially for high‑risk or relapsed patients. Long‑term...
The Substance Abuse and Mental Health Services Administration (SAMHSA) issued an advisory outlining a multi‑pronged plan to close behavioral health service gaps in U.S. “desert” areas. It calls for expanding tele‑behavioral health, embedding mental‑health clinicians in primary‑care settings, and offering...
The CDC’s March 26 report shows U.S. child vaccination coverage by age two remained broadly stable, but five vaccines saw measurable declines. Flu coverage dropped 7.4 percentage points, while hepatitis B birth dose, rotavirus, pneumococcal conjugate, and Hib each fell between 1...
Banner | Aetna, the Arizona health‑plan joint venture of Banner Health and Aetna, is participating in the 2026 Phoenix Heart Walk as a member of the event’s Executive Leadership Team. CFO Dan Keller volunteers his time, highlighting a personal connection to heart...
The Healthcare Financial Management Association (HFMA) will host its 2026 Annual Conference June 7‑10 at the Gaylord Resort & Conference Center in National Harbor, Maryland, drawing more than 4,000 finance leaders and solution partners. The event introduces a reimagined on‑site...
Hospitals face billing ambiguity for medical supplies under IPPS and OPPS, where many items are bundled into procedure payments. A clear billable supply policy distinguishes routine from non‑routine items, preventing inconsistent patient charges and aiding charge capture. The article outlines...
New real‑world analysis of 482 acute myeloid leukemia patients shows tyrosine kinase inhibitors produce comparable overall survival and event‑free survival across racial and ethnic groups. The study, using the Flatiron Health Research Database from 2015‑2023, captured patients treated with FLT3,...
Latent Space as a Physiological Map: All our medical data, genomes, scans, notes are just different shadows of one underlying physiological state. Health = a point in high-dimensional space. Disease = a drifting trajectory Treatment = a vector,...
The Veterans Health Administration has rolled out an agentic AI operating system across more than 150 VA medical centers and outpatient facilities, serving up to 18 million veterans. Built on Salesforce’s Slack platform, the solution unifies clinicians, administrators and caregivers, automating...
The UK government has issued new guidance urging parents to limit screen time for children under five to no more than one hour a day. The advice, backed by health experts, includes practical “screen‑swap” strategies and applies stricter limits for...
Rosen Law Firm has filed a securities‑fraud class action against Corcept Therapeutics and opened a class‑action investigation into Aldeyra Therapeutics following FDA setbacks. The actions give investors a chance to seek compensation and set a deadline of April 21, 2026...
The Centers for Medicare & Medicaid Services released its first dataset showing how many ACA Open Enrollment participants received help from certified brokers, agents, or other assisters. The data, limited to the 30 states that use the federal HealthCare.gov exchange,...
China announced a three‑year plan to extend its long‑term care insurance system to 45 million seniors with disabilities or dementia. The move builds on a pilot that has enrolled 310 million people since 2016 and already helped over 3.3 million disabled citizens. Insurers...
Researchers at Ruhr University Bochum, Houston Methodist and the University of Johannesburg have unveiled three nanomedicine platforms—a light‑activated copper nanoparticle, a magnetically guided superparamagnetic carrier and a liposome‑encapsulated photodynamic therapy—that each claim to dramatically improve precision for cancer or spinal‑cord...
MRI classification systems are reshaping spinal stenosis care by replacing vague descriptors with structured grading such as the Schizas system for lumbar canals and analogous cervical scales. These standardized frameworks improve inter‑observer reliability, align imaging findings with surgical observations, and...
Modern Dental Group Ltd announced full‑year earnings of HK$596.97 million, a 46% increase from the prior year, with revenue climbing 11.1% to HK$3.74 billion. The results arrive as the company faces a packed FDA calendar that could unlock further market opportunities for...
The elephant in the room? Healthcare talks endlessly about prevention. But who, exactly, gets paid when you don’t get sick? Follow the incentives and the whole story changes. Until staying healthy becomes more profitable than treating disease, prevention will keep being marketed like a...
Mochi Health announced its role as a Premiere Sponsor of the Livelong Women’s Health Summit, scheduled for April 17‑18 in San Francisco. Founder and CEO Myra Ahmad, M.D., will headline a session on GLP‑1 medications and host a roundtable on...
At the Sunshine Eye & Retina conference, ophthalmologist Dr. Sumit Sharma outlined a tiered referral framework for uveitis based on specific ocular findings. Same‑day referrals are mandated for necrotizing retinitis, immunocompromised patients with posterior disease, and hypopyon accompanied by severe pain or...
![[Obituary] Alan R Hinman](/cdn-cgi/image/width=1200,quality=75,format=auto,fit=cover/https://hixhlmpcokxhartfkpyi.supabase.co/storage/v1/object/public/images/thumbnails/91c730229d2cdf07e809bf1e54e9b27e.webp)
Alan R. Hinman, a pioneering epidemiologist and former CDC Assistant Surgeon General, died on Jan 26, 2026 at age 88. He led the CDC Immunization Division, tightening school vaccine mandates and slashing measles cases, and later directed the National Center for Prevention Services....
![[Comment] New Hope for Neurotrophin Targeting in Osteoarthritis Pain?](/cdn-cgi/image/width=1200,quality=75,format=auto,fit=cover/https://hixhlmpcokxhartfkpyi.supabase.co/storage/v1/object/public/images/thumbnails/754aaf1faeb0d5f3b76618daddf79401.webp)
Osteoarthritis (OA) remains a massive global health challenge with no disease‑modifying drugs and only modestly effective analgesics. The anti‑NGF monoclonal antibody, introduced in 2010, delivered unprecedented pain relief but was halted in 2021 after the FDA and EMA flagged joint...
![[Editorial] Politicisation of the US FDA: Eroding Integrity and Trust](/cdn-cgi/image/width=1200,quality=75,format=auto,fit=cover/https://hixhlmpcokxhartfkpyi.supabase.co/storage/v1/object/public/images/thumbnails/2cbcac9eecf69b15e3915028747699be.webp)
The editorial warns that increasing political interference is eroding the US Food and Drug Administration’s integrity and public trust. With a 2026 budget of $6.8 billion, the FDA remains the world’s most influential drug regulator, tasked with safeguarding safety while accelerating...
Health care spending in the U.S. rose from about 5% of GDP in 1960 to 17% in 2010, then slowed markedly after 2010. Cutler and Klarnet attribute the slowdown to five factors—cost‑saving technology (≈21%), reduced demand (10‑26%), supply‑side price reductions...
A new JAMA analysis of more than 2.6 million women shows mammography use among 40‑ to 49‑year‑olds fell roughly 10% between 2002 and 2022. The decline was modest overall but reached up to 12% in specific sociodemographic groups, including uninsured women...
Magee-Womens Research Institute (MWRI) expanded to Erie, Pennsylvania, establishing a research hub that supports 44 active clinical studies and over 2,700 patient visits. The institute now employs more than 380 scientists nationwide, running 319 studies covering 292 conditions and enrolling...
The Patented Medicine Prices Review Board (PMPRB) released seven proposed Practice Directions to modernize its hearing procedures. It proposes default paper hearings for evidentiary matters, electronic filing, standardized motions, AI disclosure, virtual oral arguments, and an expedited failure‑to‑file process with...
Teledermatology is emerging as a core component of skin‑care delivery, especially for patients requiring frequent monitoring such as those on isotretinoin. Virtual visits excel at follow‑up appointments, safety checks, and prescription renewals, but current imaging technology cannot reliably diagnose pigmented...
The National Institutes of Health released the FY26‑FY33 Strategic Plan for Disability Health Research, outlining a coordinated, person‑centered approach to improve health outcomes for people with disabilities. Developed with input from researchers, clinicians, advocates, and individuals with lived experience, the...
MiniMed secured FDA clearance for the MiniMed Flex, its smallest insulin pump yet, featuring a fully smartphone‑controlled, screenless design. The pocket‑sized device is roughly half the size of the 780G and holds a 300‑unit insulin reservoir while integrating continuous glucose...
Just over here longing for a world where every real ED could be more like the Pitt - Heartfelt humans - Competent care - No patients' needs dismissed
Omada is between-visit care for real life. Now that care includes cholesterol management. More than 86 million Americans are living with high cholesterol. Our new program, Omada for Cholesterol, includes health coaching, peer support, and guidance from a clinical specialist trained...
LEO Pharma presented long‑term results from the five‑year EFFISAYIL ON extension, showing subcutaneous SPEVIGO® reduced generalized pustular psoriasis (GPP) flares from an average of two per year to 0.13, with 74.6% of patients experiencing no flares over three years. Intravenous SPEVIGO...
“Huntington’s Disease and The Triad of Therapeutic Conviction”. Debut blog from Eric Green, CEO of Trace Neuro, explaining why and how advances are happening in HD. Genetics, cellular understanding, and enabling modalities. https://t.co/pAr9EQs5gJ
HOW does a hospital end up hiring a dietitian who “didn't know where intestines were”?! 😳 A sign of our times, perhaps? Tut-tut. Via @JHumphriesBBC @BBC https://t.co/PeXXIkdw0c
GLP‑1 receptor agonists, such as exenatide, have shown the ability to lower intracranial pressure (ICP) in patients with idiopathic intracranial hypertension (IIH) independent of weight loss. In a double‑masked, placebo‑controlled trial, exenatide reduced ICP by 5.7 cm H₂O within 2.5 hours, with the...
Amid the Trump administration's focus on food, a key FDA leader briefs lawmakers on the agency's plans https://t.co/SrXI4ObmGF
TrumpRx, launched early 2026, is a direct‑to‑patient portal offering more than 40 drugs with cash‑pay prices, coupons and discounts. The platform aligns with the administration’s most‑favored‑nation (MFN) pricing policy, but the listed prices do not always match the official MFN...
VIVAZEN® welcomed a House Energy and Commerce subcommittee hearing on H.R. 8000, the End Needless Distribution of 7‑OH Act, urging the DEA to promptly schedule the synthetic opioid 7‑hydroxymitragynine. The company highlighted public‑health risks such as toxicity, dependence and market confusion...
Has anyone mapped this into what consumers *want* and/or *value*? The sucky pay for family medicine is glaring; what about others? @HealthyThinker
Korean biotech is gaining global visibility after the East‑West Biopharma Summit highlighted its first‑in‑class pipelines. The Korean Ministry of Health and Welfare announced that Eli Lilly will invest $500 million over the next five years to collaborate with domestic firms. The deal...
Medtronic is recalling 26,851 MiniMed 780G insulin pumps after identifying three software defects across versions 6.60, 6.61 and 6.62. The FDA classified the recall as Class II, indicating temporary health risks if unaddressed. Medtronic’s remedy is a firmware update to version 6.62 and...
